Company Profile

Hovione has over 58 years of experience as a CDMO and is currently a fully integrated supplier offering from drug substance to drug product intermediate to drug product. With four FDA inspected sites in Portugal, the U.S., Ireland and China, Hovione provides branded pharmaceutical customers services for the development and compliant manufacture of innovative drugs including highly potent compounds, niche generic API products, and offers proprietary product development and licensing opportunities for drug products. In the last 5 years it stood behind 3-4 NDA approvals each year, and its DMFs and CEPs are referenced in dozens of ANDAs and marketing authorization that are approved each year. Hovione is a company with a culture based on innovation, quality and delivery.